PGNY

Progyny, Inc.

Healthcare · $1.9B market cap

Verdict

Share price

$25.23

close of Oct 3, 2026

Fair value

$50.72

Sticker Price

Payback Price

$20.29

buy price

Undervalued

PGNY is Undervalued: at $25.23 it trades 50% below its fair value of $50.72. Its buy price (Payback Price) is $20.29, 20% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth6.2% a year✗
Equity per share growth25.5% a year✓
Sales growth45.9% a year✓
Free cash flow growth49.1% a year✓
Return on invested capital9.7%✗

Follow PGNY

Get notified when it reaches its buy price of $20.29. Free.

Create a free account

Superinvestors

1 of the investors we track holds PGNY. Who we track

Insider activity

Since Jun 17, 2026: no open-market purchases, 1 sale worth $71K and 9 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Progyny, Inc.

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier…

Medical - Healthcare Plans

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works